Vadakke Puthiyottil SS, Edayattil A, N K S. Pathologic Response to Neoadjuvant Subcutaneous Fixed-Dose Pertuzumab–Trastuzumab (Phesgo®) and Chemotherapy in HER2-Positive Locally Advanced Breast Cancer: A Case Series and Literature Review. Asian Pac J Cancer Care [Internet]. 2026 May 2 [cited 2026 Jun. 12];11(3):481-8. Available from: http://www.waocp.com/journal/index.php/apjcc/article/view/1994